Microba Life Sciences Limited (ASX: MAP)
Australia
· Delayed Price · Currency is AUD 0.195
+0.010 (5.41%)
Dec 27, 2024, 3:28 PM AEST
Microba Life Sciences Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
| Revenue | 12.09 | 12.09 | 5.42 | 4.69 | 3.73 | 2.91 | Upgrade
|
| Revenue Growth (YoY) | 123.06% | 123.06% | 15.60% | 25.62% | 28.31% | 59.12% | Upgrade
|
| Cost of Revenue | 6.18 | 6.18 | 2.74 | 2.32 | 1.69 | 1.48 | Upgrade
|
| Gross Profit | 5.91 | 5.91 | 2.68 | 2.37 | 2.04 | 1.43 | Upgrade
|
| Selling, General & Admin | 15.11 | 15.11 | 10.18 | 10.27 | 7.31 | 6.89 | Upgrade
|
| Research & Development | 10.84 | 10.84 | 9.34 | 5.38 | 2.1 | 0.16 | Upgrade
|
| Other Operating Expenses | 2.92 | 2.92 | 1.75 | 1.44 | 0.93 | 0.75 | Upgrade
|
| Operating Expenses | 31.74 | 31.74 | 22.91 | 18.64 | 11.56 | 8.9 | Upgrade
|
| Operating Income | -25.84 | -25.84 | -20.23 | -16.27 | -9.52 | -7.47 | Upgrade
|
| Interest Expense | -0.07 | -0.07 | -0.06 | -0.06 | -0.02 | -0.04 | Upgrade
|
| Interest & Investment Income | 1 | 1 | 0.88 | 0.05 | 0.1 | 0.1 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.1 | 0.1 | 0.37 | 0.49 | -0.05 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 5.82 | 5.82 | 6.37 | 4.32 | 1.97 | 0.75 | Upgrade
|
| EBT Excluding Unusual Items | -18.98 | -18.98 | -12.67 | -11.46 | -7.52 | -6.66 | Upgrade
|
| Merger & Restructuring Charges | -1.01 | -1.01 | - | - | - | - | Upgrade
|
| Pretax Income | -19.99 | -19.99 | -12.67 | -11.46 | -7.52 | -6.66 | Upgrade
|
| Income Tax Expense | -0.05 | -0.05 | 0.01 | 0.01 | - | -0.01 | Upgrade
|
| Net Income | -19.94 | -19.94 | -12.68 | -11.47 | -7.52 | -6.65 | Upgrade
|
| Net Income to Common | -19.94 | -19.94 | -12.68 | -11.47 | -7.52 | -6.65 | Upgrade
|
| Shares Outstanding (Basic) | 410 | 410 | 314 | 223 | 183 | 157 | Upgrade
|
| Shares Outstanding (Diluted) | 410 | 410 | 314 | 223 | 183 | 157 | Upgrade
|
| Shares Change (YoY) | 30.42% | 30.42% | 40.87% | 21.61% | 17.01% | - | Upgrade
|
| EPS (Basic) | -0.05 | -0.05 | -0.04 | -0.05 | -0.04 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.05 | -0.04 | -0.05 | -0.04 | -0.04 | Upgrade
|
| Free Cash Flow | -17.05 | -17.05 | -12.94 | -12.08 | -7.43 | -4.68 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.04 | -0.05 | -0.04 | -0.03 | Upgrade
|
| Gross Margin | 48.85% | 48.85% | 49.41% | 50.46% | 54.61% | 49.04% | Upgrade
|
| Operating Margin | -213.71% | -213.71% | -373.24% | -347.05% | -255.09% | -256.80% | Upgrade
|
| Profit Margin | -164.92% | -164.92% | -233.95% | -244.64% | -201.58% | -228.62% | Upgrade
|
| Free Cash Flow Margin | -141.06% | -141.06% | -238.82% | -257.75% | -199.04% | -161.02% | Upgrade
|
| EBITDA | -24.61 | -24.61 | -19.09 | -15.56 | -8.95 | -6.86 | Upgrade
|
| EBITDA Margin | -203.56% | -203.56% | - | - | -239.87% | -235.97% | Upgrade
|
| D&A For EBITDA | 1.23 | 1.23 | 1.14 | 0.72 | 0.57 | 0.61 | Upgrade
|
| EBIT | -25.84 | -25.84 | -20.23 | -16.27 | -9.52 | -7.47 | Upgrade
|
| EBIT Margin | -213.71% | -213.71% | - | - | -255.09% | -256.80% | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.